Estradiol Benzoate: Precision Estrogen Receptor Alpha Agonist for Research

Executive Summary: Estradiol Benzoate (SKU: B1941) is a synthetic estradiol analog developed by APExBIO, functioning as a potent estrogen/progestogen receptor agonist with high affinity for estrogen receptor alpha (ERα) (IC₅₀: 22–28 nM) across human, murine, and avian models (APExBIO). It is supplied in solid form with a molecular weight of 376.49 g/mol and a chemical formula of C₂₅H₂₈O₃. The compound is insoluble in water, but demonstrates excellent solubility in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL). Estradiol Benzoate is validated by HPLC, MS, and NMR for purity (≥98%) and is critical for dissecting estrogen receptor-mediated signaling pathways in hormone-dependent cancer and endocrinology research (see advanced insights). Storage at -20°C is required for stability, and solutions should only be used short-term to avoid degradation (product documentation).

Biological Rationale

Estradiol Benzoate is engineered as a synthetic analog of 17β-estradiol, the primary endogenous estrogen in mammals (APExBIO). It binds with high specificity to estrogen receptor alpha (ERα), a nuclear hormone receptor central to the regulation of gene transcription in reproductive and endocrine tissues. The compound also functions as a progestogen receptor agonist, enabling the study of dual hormone receptor signaling. Its robust affinity for ERα makes it a preferred tool in the characterization of estrogen-dependent signaling cascades, especially in research focused on hormone-dependent cancers such as breast and endometrial carcinoma (see mechanistic precision).

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate is an agonist that activates ERα by direct, high-affinity binding (IC₅₀: 22–28 nM), as confirmed in both in vitro and in vivo models. Upon binding, the ligand-receptor complex translocates to the nucleus, where it modulates the transcription of estrogen-responsive genes. This leads to alterations in cell proliferation, differentiation, and survival signals. In research settings, Estradiol Benzoate is used to stimulate or modulate receptor-mediated signaling, dissecting the molecular events underlying estrogen-driven physiology and pathophysiology. Its esterified benzoate group confers increased metabolic stability compared to unmodified estradiol, extending its activity in experimental systems (APExBIO product details).

Evidence & Benchmarks

• Estradiol Benzoate exhibits high-affinity binding to ERα in human, murine, and chicken tissues with an IC₅₀ range of 22–28 nM (APExBIO).
• Validated purity (≥98%) via HPLC, mass spectrometry (MS), and NMR, ensuring suitability for quantitative biochemical assays (APExBIO QC data).
• Demonstrates effective solubility in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL), enabling flexible integration into diverse assay formats (APExBIO).
• Widely referenced for use in hormone receptor binding assays and estrogen receptor signaling research (Advanced Insights).
• Recommended for use in research only; not intended for diagnostic or therapeutic applications (APExBIO).

Applications, Limits & Misconceptions

Estradiol Benzoate is a cornerstone in molecular endocrinology and hormone-dependent cancer research. Its primary applications include:

• Elucidation of estrogen receptor-mediated signal transduction in cell models.
• Benchmarking of synthetic and natural estrogen analogs in receptor binding assays.
• Characterization of ligand-dependent transcriptional responses in hormone-responsive cancer lines (see strategic horizons—this article contrasts by providing a detailed guide for workflow integration and pitfalls).
• As a positive control in hormone receptor binding and activation studies.

However, Estradiol Benzoate is strictly for research use. It is not suitable for in vivo therapeutic studies or clinical diagnostics. Solubility is limited to organic solvents; aqueous formulations are not feasible. The compound's activity is contingent on receptor expression and cellular context (see molecular insights—this article provides direct workflow guidance and stability data, which previous guides summarize less explicitly).

Common Pitfalls or Misconceptions

• Not for clinical or diagnostic use: Estradiol Benzoate is supplied for research purposes only and is not approved for therapeutic administration (APExBIO).
• Water insolubility: Estradiol Benzoate is not soluble in water. Attempts to use aqueous buffers will result in precipitation and loss of activity.
• Short-term solution stability: Solutions degrade rapidly at room temperature or upon repeated freeze-thaw; fresh aliquots should be prepared for each experiment.
• Receptor specificity: Biological effects are mediated primarily via ERα; responses in cells lacking this receptor may be absent or non-specific.
• Conflation with unmodified estradiol: The benzoate ester confers distinct pharmacokinetic and stability properties compared to free estradiol, impacting experimental outcomes.

Workflow Integration & Parameters

Preparation: Dissolve Estradiol Benzoate in DMSO (≥12.15 mg/mL) or ethanol (≥9.6 mg/mL) to prepare stock solutions. Store solid material and stock at -20°C; avoid repeated freeze-thaw cycles. Solutions should be used within one week to minimize degradation.

Experimental Use: Typical concentrations for cell-based assays range from 1 nM to 1 μM, depending on cell type and receptor density. For hormone receptor binding assays, titrate to determine optimal IC₅₀ in the specific biological context. Use organic solvent stocks to spike into culture media; final DMSO/ethanol concentration should not exceed 0.1% v/v to avoid cytotoxicity.

Controls: Always include solvent-only controls to account for vehicle effects. For comparative studies, benchmark against other synthetic or natural estrogens where appropriate.

Shipping is performed on blue ice to maintain product integrity. Each batch is accompanied by HPLC, MS, and NMR quality assurance data (Estradiol Benzoate product page).

Conclusion & Outlook

Estradiol Benzoate from APExBIO (SKU: B1941) is a rigorously characterized, high-purity tool compound for dissecting estrogen receptor alpha-mediated signaling in research environments. Its defined binding affinity, stability, and solubility profiles make it indispensable for hormone receptor binding assays and advanced endocrinology workflows. By adhering to best-practice storage and use parameters, researchers can ensure reproducible, high-fidelity results. For further exploration of mechanistic and strategic applications, see this article on next-gen signaling research, which this guide extends by providing detailed workflow and benchmarking data.